Our recent report suggested a decrease of proprotein convertase subtilisin/kexin type 9 (PCSK9) activity linked to an alteration of serine-phosphorylation as an underlying mechanism of FXS associated hypocholesterolemia22. The gene discussed is PCSK9; the disease is fragile X syndrome.